CORONARY ARTERY BYPASS GRAFT

Clinical trials for CORONARY ARTERY BYPASS GRAFT explained in plain language.

Never miss a new study

Get alerted when new CORONARY ARTERY BYPASS GRAFT trials appear

Sign up with your email to follow new studies for CORONARY ARTERY BYPASS GRAFT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1 Completed 2

Could a simple supplement shield your heart during bypass? new trial aims to find out.

Disease control Not yet recruiting

This study tests whether taking nicotinamide mononucleotide (NMN), a natural compound, before and after coronary bypass surgery can reduce damage to the heart and kidneys. About 90 adults at higher risk for complications will receive either NMN or a placebo. The goal is to see if…

Matched conditions: CORONARY ARTERY BYPASS GRAFT

Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control

Last updated May 22, 2026 13:52 UTC

CORONARY ARTERY BYPASS GRAFT

Get alerted when new CORONARY ARTERY BYPASS GRAFT trials appear

Could a simple supplement shield your heart during bypass? new trial aims to find out.